These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Familial nephropathy with hyperuricemia and gout. Leumann EP; Wegmann W Nephron; 1983; 34(1):51-7. PubMed ID: 6855996 [TBL] [Abstract][Full Text] [Related]
7. Restoration of the uricosuric effect of probenecid after triglycylvasopressine administration in a gouty patient. Decaux G; Soupart A; Musch W; Hannotier P; Prospert F Clin Nephrol; 1998 Oct; 50(4):262-5. PubMed ID: 9799074 [TBL] [Abstract][Full Text] [Related]
8. Newly discovered familial juvenile gouty nephropathy in a Japanese family. Saeki A; Hosoya T; Okabe H; Saji M; Tabe A; Ichida K; Itoh K; Joh K; Sakai O Nephron; 1995; 70(3):359-66. PubMed ID: 7477627 [TBL] [Abstract][Full Text] [Related]
9. Influence of urate-lowering therapies on renal handling of uric acid. Ma L; Wei L; Chen H; Zhang Z; Yu Q; Ji Z; Jiang L Clin Rheumatol; 2016 Jan; 35(1):133-41. PubMed ID: 25373449 [TBL] [Abstract][Full Text] [Related]
10. Biochemical effectiveness of allopurinol and allopurinol-probenecid in previously benzbromarone-treated gout patients. Reinders MK; van Roon EN; Houtman PM; Brouwers JR; Jansen TL Clin Rheumatol; 2007 Sep; 26(9):1459-65. PubMed ID: 17308859 [TBL] [Abstract][Full Text] [Related]
11. Hyperuricemia, gout and the kidney. Gibson T Curr Opin Rheumatol; 2012 Mar; 24(2):127-31. PubMed ID: 22157498 [TBL] [Abstract][Full Text] [Related]
12. Stronger Uricosuric Effects of the Novel Selective URAT1 Inhibitor UR-1102 Lowered Plasma Urate in Tufted Capuchin Monkeys to a Greater Extent than Benzbromarone. Ahn SO; Ohtomo S; Kiyokawa J; Nakagawa T; Yamane M; Lee KJ; Kim KH; Kim BH; Tanaka J; Kawabe Y; Horiba N J Pharmacol Exp Ther; 2016 Apr; 357(1):157-66. PubMed ID: 26907620 [TBL] [Abstract][Full Text] [Related]
13. Urate transport via human PAH transporter hOAT1 and its gene structure. Ichida K; Hosoyamada M; Kimura H; Takeda M; Utsunomiya Y; Hosoya T; Endou H Kidney Int; 2003 Jan; 63(1):143-55. PubMed ID: 12472777 [TBL] [Abstract][Full Text] [Related]
14. Control of renal uric acid excretion and gout. Taniguchi A; Kamatani N Curr Opin Rheumatol; 2008 Mar; 20(2):192-7. PubMed ID: 18349750 [TBL] [Abstract][Full Text] [Related]
16. Renal handling of uric acid in man. Levinson DJ; Decker DE; Sorensen LB Ann Clin Lab Sci; 1982; 12(1):73-7. PubMed ID: 7065639 [TBL] [Abstract][Full Text] [Related]
17. [Historical review of gout and hyperuricemia investigations]. Nakamura T Nihon Rinsho; 2008 Apr; 66(4):624-35. PubMed ID: 18409506 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol. Reinders MK; van Roon EN; Jansen TL; Delsing J; Griep EN; Hoekstra M; van de Laar MA; Brouwers JR Ann Rheum Dis; 2009 Jan; 68(1):51-6. PubMed ID: 18250112 [TBL] [Abstract][Full Text] [Related]
19. Chronic kidney disease in an adolescent with hyperuricemia: familial juvenile hyperuricemic nephropathy. Alaygut D; Torun-Bayram M; Soylu A; Kasap B; Türkmen M; Kavukçu S Turk J Pediatr; 2013; 55(6):637-40. PubMed ID: 24577984 [TBL] [Abstract][Full Text] [Related]